Zenlabs Ethica Ltd. (ZENLABS)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
27. 50
+0.28
+1.0287%
₹
123.69M Market Cap
- P/E Ratio
- Div Yield
420 Volume
0 Eps
₹ 27.22
Previous Close Want to track ZENLABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ZENLABS trading today higher at ₹27.5, an increase of 1.0287% from yesterday's close, completing a monthly decrease of -15.4106% or -₹5.01. Over the past 12 months, ZENLABS stock gained 27.0208%.
ZENLABS is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zenlabs Ethica Ltd. has completed 1 stock splits, with the recent split occurring on Oct 11, 2018.
The company's stock is traded on one exchange.
ZENLABS Chart
People also search for
Zenlabs Ethica Ltd. (ZENLABS) FAQ
What is the stock price today?
The current price is ₹27.50.
On which exchange is it traded?
Zenlabs Ethica Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is ZENLABS.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 123.69M.
Has Zenlabs Ethica Ltd. ever had a stock split?
Zenlabs Ethica Ltd. had 1 splits and the recent split was on Oct 11, 2018.
Zenlabs Ethica Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Sanjeev Kumar Singal CEO | MSE Exchange | INE546F01013 ISIN |
| India Country | 65 Employees | 29 Jul 2022 Last Dividend | 11 Oct 2018 Last Split | - IPO Date |
Zenlabs Ethica Ltd. is a prominent entity in the pharmaceutical industry, primarily engaged in the research, development, and manufacturing of healthcare products. Its portfolio includes a diverse range of pharmaceuticals, nutraceuticals, and specialty chemicals, addressing various treatment areas such as cardiovascular, anti-diabetic, and dermatological ailments. Zenlabs Ethica prioritizes ethical practices and cutting-edge innovation, aiming to enhance patient compliance and therapeutic efficacy. The company is significant within the healthcare sector, leveraging advanced technologies and robust research capabilities to deliver high-quality, affordable medication. As a player in the global market, Zenlabs Ethica consistently collaborates with healthcare professionals and research institutions to foster an ecosystem of continuous improvement and sustainable practices. Its commitment to quality and innovation solidifies its role as a key contributor to public health advancements in both established and emerging markets.
Contact Information
Address: Plot No. 194-195
Phone: 91 17 2465 1105
Website: https://www.zenlabsethica.com
